Lemon Myrtle

Lemon myrtle leaves contain citral isomers—geranial and neral—comprising up to 88.67% of the essential oil, which exert antimicrobial, antioxidant, and anti-adipogenic effects through inhibition of inflammatory mediators and adipogenic transcription factors. In vitro assays demonstrate a DPPH radical scavenging IC50 of 42.57 μg/mL and an EC50 of 20.03 μg/mL in ferric reducing antioxidant power tests, though human clinical trial data remain absent from the published literature.

Origin & History

Backhousia citriodora is a subtropical rainforest tree native to Queensland, Australia, growing naturally along the coastal ranges from Brisbane to Mackay. It thrives in well-drained, fertile soils with high humidity and is now cultivated commercially in plantation settings across northeastern Australia for its leaves and essential oil. Aboriginal Australians have used the plant for generations, and commercial cultivation expanded significantly in the 1990s as global interest in Australian bush foods and botanical extracts grew.

Historical & Cultural Context

Backhousia citriodora has been part of Aboriginal Australian cultural and medicinal traditions for thousands of years, with leaves used to address coughs, respiratory ailments, and as an aromatic antiseptic applied topically to wounds and skin conditions. The plant holds cultural significance among Queensland coastal Aboriginal communities who harvested leaves from wild trees within subtropical rainforest ecosystems. European botanical documentation began in the 19th century, with the genus named after the English botanist James Backhouse, and commercial interest in the species grew substantially during the Australian bush food movement of the late 20th century. Today, lemon myrtle is regarded as one of Australia's most commercially significant native botanical ingredients, incorporated into teas, condiments, cosmetics, and nutraceutical products internationally.

Health Benefits

- **Antioxidant Activity**: The essential oil of Backhousia citriodora exhibits strong free-radical scavenging capacity, with a DPPH IC50 of 42.57 μg/mL and FRAP EC50 of 20.03 μg/mL, attributable primarily to its high citral content and secondary phenolics including gallic acid and ellagic acid.
- **Anti-inflammatory Effects**: Leaf extracts suppress nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 macrophage cells, indicating inhibition of the NF-κB-driven inflammatory cascade mediated by geranial and neral components.
- **Antimicrobial and Antibiofilm Properties**: Lemon myrtle essential oil demonstrates broad-spectrum antibacterial and antifungal activity consistent with the Myrtaceae family, with citral disrupting microbial membrane integrity and inhibiting biofilm formation on multiple organism types.
- **Potential Anti-Adipogenic Effects**: Citral and lemon myrtle essential oil suppressed MDI-induced differentiation of 3T3-L1 preadipocytes and downregulated the expression of key adipogenic transcription factors including PPARγ and C/EBPα, suggesting a mechanistic role in weight management.
- **Respiratory Soothing Properties**: Traditional Aboriginal use of lemon myrtle leaves for coughs and respiratory complaints is supported by the known expectorant and antimicrobial properties of high-citral essential oils, which may reduce microbial colonization in the upper respiratory tract.
- **Phenolic Antioxidant Load**: Aqueous leaf extracts yield total phenolic content of 35.8–43.9 μg/g, with the highest yield at 80°C for 6 hours; flavonoids such as rutin, luteoloside, and quercetin contribute to vascular protective and anti-inflammatory potential.
- **Natural Flavoring and Aromatic Use**: Lemon myrtle is generally regarded as safe as a food flavoring and aromatic agent, with culinary applications providing low-dose exposure to bioactive citral isomers and polyphenols that may contribute to dietary antioxidant intake.

How It Works

The dominant bioactive constituents, geranial (52.13%) and neral (37.65%), collectively termed citral, act primarily by disrupting microbial cell membranes and inhibiting microbial enzyme systems, accounting for the essential oil's broad antimicrobial profile. In macrophage cell models, lemon myrtle extracts suppress LPS-induced nitric oxide synthesis, likely through downregulation of inducible nitric oxide synthase (iNOS) expression via interference with NF-κB signaling pathways. In preadipocyte models, citral inhibits the MDI-induced upregulation of PPARγ and CCAAT/enhancer-binding protein alpha (C/EBPα), transcription factors essential to lipid accumulation and adipogenesis, suggesting modulation of lipogenic gene networks. Secondary phenolics—gallic acid, ellagic acid, catechin, quercetin, and rutin—contribute antioxidant activity through electron donation and metal chelation, while flavonoids may additionally modulate cyclooxygenase activity to reduce eicosanoid-driven inflammation.

Scientific Research

Published research on Backhousia citriodora consists almost entirely of in vitro chemical characterization and cell-based mechanistic studies, with no registered human clinical trials identified in the peer-reviewed literature as of 2024. Gas chromatography-mass spectrometry analyses have rigorously characterized the essential oil composition, identifying 21 compounds representing 98.50% of total oil content, providing a robust phytochemical foundation. Cell culture studies in RAW 264.7 macrophages and 3T3-L1 preadipocytes have generated reproducible mechanistic data, but extrapolation to human physiology is limited by species differences and the absence of pharmacokinetic data in humans. The overall evidence base is preclinical, and while chemically well-characterized, lemon myrtle's clinical efficacy, optimal human dosing, and safety profile in therapeutic contexts require prospective human investigation before evidence-based recommendations can be made.

Clinical Summary

No published human clinical trials specifically evaluating Backhousia citriodora as a therapeutic or supplemental agent were identified in the available literature. Existing studies are limited to in vitro antioxidant assays, cell-based anti-inflammatory and anti-adipogenic models, and essential oil compositional analyses. Preclinical outcomes—including IC50 values for DPPH scavenging and inhibition of adipogenic transcription factors—are promising but cannot be directly translated to clinical effect sizes or human dose-response relationships. Confidence in therapeutic recommendations remains low pending prospective, controlled human trials.

Nutritional Profile

Lemon myrtle leaves are nutritionally modest as a whole food but phytochemically rich. The essential oil fraction, representing the primary bioactive component, is dominated by citral isomers (geranial 52.13%, neral 37.65%) alongside minor terpenes including β-myrcene (0.22%), linalool (0.53%), and cyclohexane derivatives. Phenolic compounds in dried leaf aqueous extracts include gallic acid, ellagic acid, catechin, quercetin, rutin, and luteoloside, with total phenolic content of 35.8–43.9 μg/g dry weight depending on extraction conditions. As a culinary herb used in small quantities, lemon myrtle contributes negligible macronutrient intake but delivers meaningful phytochemical diversity; bioavailability of citral and phenolics from food-grade preparations is presumed moderate but has not been formally studied with pharmacokinetic methods in humans.

Preparation & Dosage

- **Dried Leaf (Culinary/Tea)**: Typically 1–2 teaspoons (approximately 2–4 g) of dried leaf steeped in boiling water for 5–10 minutes; used traditionally for cough relief and as a wellness tea with no standardized therapeutic dose established.
- **Essential Oil (Topical/Aromatic)**: Commonly diluted to 1–2% in a carrier oil for topical antimicrobial or aromatic applications; internal use of essential oil is not recommended due to high citral concentration and lack of safety data for oral dosing.
- **Leaf Powder (Food Supplement)**: Available in encapsulated form at 300–500 mg per capsule in commercial Australian bush food supplements; no clinically validated dose exists for therapeutic purposes.
- **Aqueous Leaf Extract**: Optimal phenolic extraction achieved at 80°C for 6 hours in research settings, yielding 43.9 μg/g total phenolics; commercial extracts vary in standardization and are not uniformly standardized to a specific citral or phenolic percentage.
- **Standardized Essential Oil**: Commercial lemon myrtle essential oil is typically standardized to ≥90% citral content; this high concentration mandates significant dilution before any use and is not appropriate for direct ingestion.
- **Timing**: No clinical timing data exist; traditional tea preparation is consumed ad libitum, typically 1–3 cups daily in culinary wellness contexts.

Synergy & Pairings

Lemon myrtle's citral content may demonstrate enhanced antimicrobial activity when combined with tea tree oil (Melaleuca alternifolia), as both disrupt microbial membrane integrity through complementary terpene mechanisms, a combination explored in Myrtaceae-based topical antimicrobial formulations. The polyphenol profile—quercetin, rutin, and gallic acid—may act synergistically with vitamin C to regenerate oxidized ascorbate radicals, enhancing the overall antioxidant network in formulations targeting oxidative stress. In culinary and nutraceutical contexts, pairing lemon myrtle with other high-phenolic Australian native botanicals such as Kakadu plum (Terminalia ferdinandiana) may provide additive antioxidant capacity through complementary flavonoid and ellagitannin contributions.

Safety & Interactions

Lemon myrtle and its extracts are generally regarded as safe (GRAS) when used as a food flavoring and culinary aromatic, with a long history of use in Australia without documented adverse events at culinary doses. The essential oil contains very high citral concentrations (>88%) and must be significantly diluted for topical use, as undiluted application may cause skin sensitization, irritation, or allergic contact dermatitis in susceptible individuals; internal use of the concentrated essential oil is not recommended. No formal drug interaction data exist in the published literature; however, given citral's cytochrome P450 modulation potential observed in related monoterpenoids, caution is theoretically warranted with medications metabolized by CYP3A4 and CYP2B6 pathways. Safety during pregnancy and lactation has not been established in clinical studies, and the use of concentrated extracts or essential oil preparations should be avoided in these populations; culinary leaf use is generally considered low-risk.